Special Issue calls for papers—Advances in Liver Xenotransplantation

Conveners: 

Prof. Guihua Chen (Editor-in-Chief of Liver Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China);

Prof. Qi Zhang (Editorial Director of Liver Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China).

Article deadline: October 8, 2024

Publishing date: December 30, 2024

Liver xenotransplantation has recently achieved great progress. On March 10, 2024, a team from Xijing Hospital, China led the transplantation of a 50-year-old brain-dead male patient who became the first person to receive a liver transplant from a genetically engineered miniature pig and was alive for 10 days. The successful completion of the world’s first gene-edited pig-to-human liver xenotransplantation indicates a significant milestone in the field of medicine.

Although there are recent advances in the pig-to-human liver xenotransplantation, major issues associated with the procedure include immune rejection, coagulation dysregulation, cross-infection, and ethical controversy. As conveners, we would like to invite investigators in the fields of liver xenotransplantation, liver transplantation, genetic modification, xenograft rejection, and immunology to contribute review articles, original articles, editorials, or commentaries to this special issue. We are particularly interested in articles that will provide important information on whether liver xenotransplantation can keep people alive and stimulate the ongoing efforts for clinical liver xenotransplantation.

Liver Research is an international, open-access, peer-reviewed English journal that publishes reviews, editorials, commentaries, conference reports, and original articles on novel developments in liver and biliary science.

Liver Research comprehensively incorporates the latest research results and diagnosis and treatment experience in the global hepatology field to promote liver disease research. Currently, Liver Research is indexed by authoritative databases including Emerging Sources Citation Index (ESCI, impact factor = 2.0), Scopus, DOAJ, Embase, and CSCD (core). The journal does not charge any fees for article processing and provides a rapid publication option. All published articles are freely and permanently available to authors and readers.

Manuscripts should be submitted online at “https://www.editorialmanager.com/livres/default.aspx” after registration. A guide for authors and other relevant information for manuscript submission are available online (https://www.keaipublishing.com/en/journals/liver-research/guide-for-authors/). Please visit the “Guide for Authors” page before submitting a manuscript.

This special issue is organized by the editor-in-chief and editorial director, and it follows the same peer review process as regular issues.